Mary Shoemaker
Direttore/Membro del Consiglio presso TRAWS PHARMA, INC.
Patrimonio netto: 2 141 $ in data 30/04/2024
Posizioni attive di Mary Shoemaker
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TRAWS PHARMA, INC. | Direttore/Membro del Consiglio | 01/04/2020 | - |
| Independent Dir/Board Member | 01/04/2020 | - |
Storia della carriera di Mary Shoemaker
Precedenti posizioni note di Mary Shoemaker
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MEDEXUS PHARMACEUTICALS INC. | Corporate Officer/Principal | - | 22/05/2020 |
Medexus Pharma, Inc.
 Medexus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Medexus Pharma, Inc. develops treatments for autoimmune diseases. It focuses on development and commercialization of treatments for autoimmune diseases as well as cancer. The company was founded in 2012 and is headquartered in Chicago, IL. | Direttore/Membro del Consiglio | 01/10/2018 | 01/05/2020 |
| Amministratore Delegato | 01/01/2012 | 01/05/2020 | |
| Presidente | 01/10/2018 | 01/05/2020 | |
| INTERMUNE INC | Vendite & Marketing | 06/11/2009 | 01/07/2010 |
Pharmion Corp.
 Pharmion Corp. Pharmaceuticals: MajorHealth Technology Pharmion Corp. engages in the development and commercialization of products for the treatment of hematology and oncology patients. It has operations in Switzerland, Israel, and Philippines. The company was founded by Patrick J. Mahaffy in 1999 and is headquartered in Boulder, CO. | Corporate Officer/Principal | - | - |
Formazione di Mary Shoemaker
| University of Central Missouri | Graduate Degree |
| Missouri State University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Canada | 2 |
Posizioni
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Sales & Marketing | 1 |
Settori
| Health Technology | 6 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| TRAWS PHARMA, INC. | Health Technology |
| MEDEXUS PHARMACEUTICALS INC. | Health Technology |
| Aziende private | 3 |
|---|---|
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Pharmion Corp.
Pharmion Corp. Pharmaceuticals: MajorHealth Technology Pharmion Corp. engages in the development and commercialization of products for the treatment of hematology and oncology patients. It has operations in Switzerland, Israel, and Philippines. The company was founded by Patrick J. Mahaffy in 1999 and is headquartered in Boulder, CO. | Health Technology |
Medexus Pharma, Inc.
Medexus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Medexus Pharma, Inc. develops treatments for autoimmune diseases. It focuses on development and commercialization of treatments for autoimmune diseases as well as cancer. The company was founded in 2012 and is headquartered in Chicago, IL. | Health Technology |
- Borsa valori
- Insiders
- Mary Shoemaker
- Esperienza
